William Blair analyst Jason Ader reiterated a Buy rating on Varonis Systems (VRNS – Research Report) today. The company’s shares opened today ...

The embedded payments and digital card company agreed to buy European electronic payments provider TransactPay for about $47 ...

William Blair analyst Jason Ader maintained a Buy rating on Nutanix (NTNX – Research Report) today. The company’s shares closed yesterday at ...

Analysts at William Blair upped their FY2025 EPS estimates for Straumann in a report issued on Monday, February 24th. William Blair analyst B. Vazquez now forecasts that the company will post earnings ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Research analysts at William Blair increased their Q1 2025 earnings estimates for shares of Tactile Systems Technology in a note issued to investors on Monday, February 24th. William Blair analyst M.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...

The new fund will invest in a niche subset of emerging markets that are 'more challenging for investors to access' ...

Insulet Corporation (NASDAQ:PODD) reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the ...

Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...